Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The skin barrier recovery pathway refers to the complex biological processes and molecular mechanisms that restore the integrity and function of the skin’s outermost layer (the stratum corneum) after it has been compromised. This pathway involves lipids, proteins, immune mediators, and cellular signaling pathways that collectively repair and regenerate the epidermal barrier. Key components include ceramides, cholesterol, free fatty acids, cornified envelope proteins, tight junctions, antimicrobial peptides, autophagy, and PAR2 signaling. Defects in this pathway underlie many dermatological conditions.
Various, depending on the specific therapeutic agent. Examples include: replenishing intercellular lipids, reducing inflammation, promoting keratinocyte differentiation, enhancing antimicrobial peptide production.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Skin Barrier Recovery Pathway (SBRP).